Cytokines as therapeutic agents and targets in heart disease

[Display omitted] •Cytokine based therapies have a potential to reduce post-infarct heart failure and chronic ischemia.•Combinations of therapeutic cytokines and substances that control cytokine levels could be more effective treatment therapy.•Further clinical studies are necessary to determine cor...

Full description

Saved in:
Bibliographic Details
Published in:Cytokine & growth factor reviews 2018-10, Vol.43, p.54-68
Main Authors: Dubnika, Arita, Manoukian, Martin A.C., Mohammadi, M. Rezaa, Parekh, Mansi Bharat, Gurjarpadhye, Abhijit Achyut, Inayathullah, Mohammed, Dubniks, Viktors, Lakey, Jonathan R.T., Rajadas, Jayakumar
Format: Article
Language:English
Subjects:
Cytokine therapies
Ischemia
Myocardial infarction
Therapeutic cytokines
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:[Display omitted] •Cytokine based therapies have a potential to reduce post-infarct heart failure and chronic ischemia.•Combinations of therapeutic cytokines and substances that control cytokine levels could be more effective treatment therapy.•Further clinical studies are necessary to determine correct targets, dosages, long-term efficiency and safety of cytokines.•Individualized cytokine based therapies could be the next major advance in the treatment of cardiovascular diseases. Cytokine therapies have emerged during the past decade as promising noninvasive treatments for heart disease. In general, current drug treatments are directed towards symptom control and prevention of disease progression; however, many agents also produce cause side effects that alter quality of life. Cytokine based therapies have the potential to reduce post-infarct heart failure and chronic ischemia by stimulating the proliferation and differentiation of endothelial cells and bone marrow hematopoietic stem cells and mobilizing these cells toward ischemic tissue. In turn, these mobilized cell populations contribute to myocardial regeneration. In contrast, over-expression of several cytokines has been linked to a variety of heart diseases; thus, therapies targeting and monitoring these cytokines are of great interest. Here we summarize results from clinical studies on cytokines as therapeutic agents or therapeutic targets in the treatment for heart disease as well as cytokines involved in the evolution of heart disease.
ISSN:1359-6101
DOI:10.1016/j.cytogfr.2018.08.003